Robeco Institutional Asset Management B.V. Has $8.08 Million Stock Position in Ventas, Inc. $VTR

Key Points

• Robeco Institutional Asset Management cut its position in Ventas by 12.7% in Q4 to 104,426 shares, valued at about $8.08 million.
• Ventas missed estimates for the quarter—reporting $0.15 EPS versus $0.89 expected and revenue below forecasts—while issuing FY2026 guidance of 3.780–3.880 EPS (sell‑side consensus ≈3.4).
• Insider sales were material: CEO Debra Cafaro sold 10,322 shares (~$801,606) and EVP Carey S. Roberts sold 35,532 shares (~$3.02 million), leaving insiders with roughly 0.53% ownership.

Robeco Institutional Asset Management B.V. lowered its stake in Ventas, Inc. (NYSE:VTR - Free Report) by 12.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 104,426 shares of the real estate investment trust's stock after selling 15,223 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Ventas were worth $8,080,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Cloud Capital Management LLC acquired a new stake in Ventas in the third quarter valued at approximately $25,000. GoalVest Advisory LLC acquired a new stake in Ventas in the fourth quarter valued at approximately $26,000. Wiser Advisor Group LLC acquired a new position in shares of Ventas during the third quarter worth $27,000. True Wealth Design LLC lifted its holdings in shares of Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust's stock worth $30,000 after purchasing an additional 405 shares during the period. Finally, ORG Partners LLC lifted its holdings in shares of Ventas by 76.1% during the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust's stock worth $32,000 after purchasing an additional 197 shares during the period. Institutional investors and hedge funds own 94.18% of the company's stock.

Insider Buying and Selling at Ventas

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the sale, the chief executive officer directly owned 1,114,034 shares of the company's stock, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president directly owned 72,755 shares of the company's stock, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.53% of the company's stock.

Ventas Price Performance

Shares of NYSE VTR opened at $84.83 on Thursday. Ventas, Inc. has a twelve month low of $61.76 and a twelve month high of $88.36. The firm has a fifty day simple moving average of $84.72 and a 200 day simple moving average of $78.90. The company has a market capitalization of $40.33 billion, a PE ratio of 157.09, a P/E/G ratio of 2.11 and a beta of 0.75. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR - Get Free Report) last announced its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the prior year, the business earned $0.81 EPS. Ventas's quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts forecast that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.5%. This is an increase from Ventas's previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas's payout ratio is presently 385.19%.

Wall Street Analyst Weigh In

VTR has been the topic of a number of recent research reports. Mizuho lifted their price target on shares of Ventas from $87.00 to $94.00 and gave the stock an "outperform" rating in a report on Wednesday, March 4th. The Goldman Sachs Group reiterated a "buy" rating and set a $100.00 price target on shares of Ventas in a report on Monday, February 9th. Weiss Ratings reiterated a "buy (b-)" rating on shares of Ventas in a report on Friday, March 27th. KeyCorp lifted their price target on shares of Ventas from $85.00 to $90.00 and gave the stock an "overweight" rating in a report on Tuesday, February 10th. Finally, Argus set a $88.00 price target on shares of Ventas in a report on Tuesday, February 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Ventas currently has a consensus rating of "Moderate Buy" and an average target price of $90.47.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.